Gender Male
Co-founder and chief executive officer at Susavion Biosciences. Dr. Wolfe also serves as a senior oncology consultant at Kantar Health, where he provides a wide range of business consulting services to both large and small pharmaceutical companies. Building on his experience at Kantar Health, he co-founded Susavion Biosciences with the vision of
advancing technology based on the discovery of multivalent, bioactive peptides that mimic carbohydrate ligands of lectin-type receptors for use as therapeutic modulators of the immune system.
